Blog | GeneralIndustry News

Amendments to the Hazardous Products Act


Notice requesting comments on a proposal to repeal and replace the Controlled Products Regulations to implement the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) in Canada, and to make consequential amendments to related regulations

Notice is hereby given that Health Canada is seeking written comments from all interested parties on a proposal to repeal and replace the Controlled Products Regulations, and make consequential amendments to related regulations, to implement the GHS in Canada.

The implementation of the GHS through the proposed regulatory amendments is intended to achieve the Canada-United States Regulatory Cooperation Council commitment to align and synchronize implementation of common classification and labelling requirements for workplace hazardous chemicals within the mandate of Health Canada and the United States Occupational Safety and Health Administration.

The proposed regulatory amendments would support the Government of Canada in facilitating international trade through common labelling and other hazard communication requirements; lowering costs for businesses and consumers by reducing the need for re-testing and re-classifying chemicals from, or for, different markets; and increasing worker protections through the adoption of a globally recognized standard for communicating the hazards associated with workplace chemicals.

In addition, amendments are being proposed to the Hazardous Materials Information Review Regulations and the Hazardous Materials Information Review Act Appeal Board Procedures Regulations to reflect amendments to the Hazardous Materials Information Review Act that came into force on April 1, 2013, as a result of the Jobs and Growth Act, 2012.


This Notice is an opportunity for the public to provide early comments and input into the proposed regulatory amendments before the regulations are prepublished in the Canada Gazette. The prepublication process will provide an additional opportunity for public consultation on the proposed regulations.

The proposed regulatory amendments will be made available to the public through Health Canada’s Web site at


Comments are closed.